| (210) | Number of the EPO application | 20710059 |
| (220) | Filing date of the EPO application | 2020.02.24 |
| (80) | EPO patent specification publication (B) | EPB nr. 07/2024, 2024.02.14 |
| (110) | EPO patent number | 3927337 |
| (11) | Number of the document | MD 3927337 T2 |
| (21) | Number of the application | e 2021 1248 |
| (71) | Name(s) of applicant(s), code of the country | GH RESEARCH IRELAND LIMITED, IE; |
| (72) | Name(s) of inventor(s), code of the country | TERWEY Theis, DE; |
| (73) | Name(s) of owner(s), code of the country | GH RESEARCH IRELAND LIMITED, IE; |
| (54) | Title of the invention | 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for treating major depression |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 31/4045 (2006.01.01); A61P 25/24 (2006.01.01) |
| (19) | Country | IE |
| (41) | Date of publication of the application | 2022.01.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2024.08.31 |
| (30) | Priority | 19158774, 2019.02.22, EP |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2020/054803, 2020.02.24 |
| (87) | International publication | WO 2020/169850, 2020.08.27 |